Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Indeed, a recent study published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology found a prolonged ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

Jake Sullivan, the outgoing national security adviser, is asking a panel of outside experts to examine the government’s ...

Nuclein’s DASH SARS-CoV-2 & Flu A/B Test, which is designed for use with the DASH Rapid PCR System, has gained the US Food ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postac ...

The following is a summary of “Four COVID-19 screening strategies for early case identification within the homeless shelter ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

A study in Ecuador reveals the rapid emergence of SARS-CoV-2 variants, highlighting the importance of strengthening genomic ...

Those days are still a way off, but a growing number of research groups are using artificial intelligence (AI) to predict the ...